Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722436 · ClinicalTrials.gov registry record · Phase 4
Tranexamic Acid for Craniofacial Surgery
A Phase 4 study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00722436 is a Phase 4 study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 20 participants.
The verdict
NCT00722436, a Phase 4 study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a randomized, blinded, prospective study that will investigate the potential benefit of tranexamic acid to reduce the intraoperative bleeding and blood transfusions in pediatric patients undergoing craniofacial surgeries.
Interventions
- DRUG Tranexamic acid
- DRUG saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00722436
The ClinicalTrials.gov registry entry for NCT00722436 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tranexamic acid is the first listed.
NCT00722436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00722436 about?
NCT00722436 is a clinical study titled "Tranexamic Acid for Craniofacial Surgery". This is a randomized, blinded, prospective study that will investigate the potential benefit of tranexamic acid to reduce the intraoperative bleeding and blood transfusions in pediatric patients undergoing craniofacial surgeries.
What is the current status of trial NCT00722436?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2008-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00722436?
The interventions under investigation include: Tranexamic acid (DRUG), saline (DRUG).
Who is sponsoring clinical trial NCT00722436?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.